Hypertensive disorders in pregnancy: 2019 National guideline
Background. Hypertensive disorders of pregnancy (HDP), including pre-eclampsia/eclampsia, account for significant maternal and fetal mortality globally and especially in South Africa.
Objective. To formulate clinical guidelines for the management of HDP in order to substantially reduce the number of maternal deaths from HDP.
Methods. The Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument was used to formulate the guidelines and included six domains: scope and purpose; stakeholder involvement; rigour and development; clarity of presentation; applicability; and editorial independence.
Recommendations. The guideline stipulates management strategies for all levels of care where women with hypertensive disorders in pregnancy are seen. It also has a detailed implementation plan.
Conclusion. A clinical guideline that is of practical value has been formulated by a wide group of stakeholders. It is hoped that its dissemination and implementation by all doctors and nurses will reduce mortality and morbidity associated with HDP.
J Moodley, Emeritus Professor: Department of Obstetrics and Gynaecology, University of KwaZulu-Natal, Durban, South Africa
P Soma-Pillay, Professor and Head: Department of Obstetrics and Gynaecology, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa
E Buchmann, Honorary Professor: Department of Obstetrics and Gynaecology, University of the Witwatersrand, Johannesburg, South Africa
R C Pattinson, Director: SAMRC/UP Maternal and Infant Care Strategies Unit, Department of Obstetrics and Gynaecology, University of Pretoria, South Africa
Full TextPDF (699KB)
Cite this article
Date published: 2019-09-13
Full text views: 701